Diablo Clinical Research Inc entered the industry of in 1995 and has grown to employ 1 to 4 people, generating an annual revenue of $5.000.000 to $9.999.999. The NAICS classifies this business under the code 6214930, which describes it as a . For further clarification, the SIC classifies this business under the code 2834 and described it as a . The business provides service to the BOTH market.
To acquire more information, please contact Catherine Morimoto, Director by calling (925) 930-7267 during business hours. You can also write to the business’ Single Location at 2255 Ygnacio Valley Road # M, Walnut Creek, California CA 94598. You can also visit the company’s website at diabloclinical.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Diablo Clinical Research Inc |
Representative: | Catherine Morimoto, Director |
Place of Business: | 2255 Ygnacio Valley Road # M, Walnut Creek, CA 94598 |
Contact Number: | (925) 930-7267 |
Website: | diabloclinical.com |
Type of Service: | |
SIC Number: | 2834 |
NAICS Number: | 6214930 |
Locality: | Single Location |
Market Type: | B2B & B2C |
Began: | 1995 |
Income/Year: | $5.000.000 to $9.999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Diablo Clinical Research Inc is a company operating from Contra Costa, California providing professional and relevant BOTH variables. It was founded in 1995 and registered with the SIC code 2834 as , and with the NAICS code 6214930 as .
With a current employee count of 1 to 4, Diablo Clinical Research Inc has gone to report making $5.000.000 to $9.999.999 per annum on its journey towards growth. This company invites you to contact its representative Catherine Morimoto, Director at (925) 930-7267 for related queries, or to locate its Single Location using the coordinates 37.92296,-122.029066.
The Single Location can also be found at the street address 2255 Ygnacio Valley Road # M in Walnut Creek, California 94598 and can be engaged online through the company website at diabloclinical.com, the company Twitter , and Facebook page .